The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cancer patients (pts) being replaced in dose-seeking phase I trials (DSP1T): Occurrence, outcome, and risk factors.
Sophie Cousin
No relevant relationships to disclose
Nicolas Isambert
No relevant relationships to disclose
Philippe Alexandre Cassier
No relevant relationships to disclose
Carlos Alberto Gomez-Roca
No relevant relationships to disclose
Nuria Kotecki
No relevant relationships to disclose
Sylvie Zanetta
No relevant relationships to disclose
Juliette Bouchet
No relevant relationships to disclose
Louis Tassy
No relevant relationships to disclose
Anne-Laure Simonet-Lamm
No relevant relationships to disclose
Eleonora De Maio
No relevant relationships to disclose
Catherine Terret
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose